(Q46445201)

English

A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer

scientific article

Statements

A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit